000 01426 a2200409 4500
005 20250511215325.0
264 0 _c19910403
008 199104s 0 0 eng d
022 _a0006-2952
024 7 _a10.1016/0006-2952(91)90070-l
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFernandes, A C
245 0 0 _aThe inhibition of lipid peroxidation by cinnarizine. Possible implications to its therapeutic and side-effects.
_h[electronic resource]
260 _bBiochemical pharmacology
_cMar 1991
300 _a709-14 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntioxidants
_xpharmacology
650 0 4 _aCinnarizine
_xpharmacology
650 0 4 _aCopper
_xpharmacology
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aErythrocytes
_xmetabolism
650 0 4 _aFemale
650 0 4 _aHemolysis
_xdrug effects
650 0 4 _aHumans
650 0 4 _aHydrogen Peroxide
_xpharmacology
650 0 4 _aLipid Peroxidation
_xdrug effects
650 0 4 _aLiver
_xmetabolism
650 0 4 _aRats
650 0 4 _aRats, Inbred Strains
650 0 4 _aThiobarbiturates
_xmetabolism
700 1 _aFilipe, P M
700 1 _aCoelho, H
700 1 _aManso, C F
773 0 _tBiochemical pharmacology
_gvol. 41
_gno. 5
_gp. 709-14
856 4 0 _uhttps://doi.org/10.1016/0006-2952(91)90070-l
_zAvailable from publisher's website
999 _c2004707
_d2004707